Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial

The evaluation of new therapeutic resources against coronavirus disease 2019 (COVID‐19) represents a priority in clinical research considering the minimal options currently available. To evaluate the adjuvant use of systemic oxygen‐ozone administration in the early control of disease progression in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2021-04, Vol.93 (4), p.2210-2220
Hauptverfasser:	Araimo, Fabio, Imperiale, Carmela, Tordiglione, Paolo, Ceccarelli, Giancarlo, Borrazzo, Cristian, Alessandri, Francesco, Santinelli, Letizia, Innocenti, Giuseppe Pietro, Pinacchio, Claudia, Mauro, Vera, Recchia, Gregorio Egidio, Zancla, Serena, Calò, Andrea, Poscia, Roberto, Ruberto, Franco, d'Ettorre, Gabriella, Bilotta, Federico, Mastroianni, Claudio, Pugliese, Francesco
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events autohemotherapy Coronaviruses COVID-19 COVID-19 - blood COVID-19 - drug therapy COVID-19 - virology Disease control Female Health services Hematology Humans Inflammation Intubation Lymphocyte Subsets - drug effects Lymphocytes Male Middle Aged Mortality Oxygen Oxygen - administration & dosage Oxygen - adverse effects Ozone Ozone - administration & dosage Ozone - adverse effects Patients Pneumonia Probiotics - administration & dosage respiratory insufficiency SARS-CoV-2 - isolation & purification Statistical analysis Subpopulations Therapy Toxicity Viral diseases Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!